Interstitial cystitis-related gene CCDC8 accelerates tumorigenesis by participating in CUL7-mediated degradation of P53 in bladder cancer
Top Cited Papers
Open Access
- 5 February 2026
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 45 (8) , 745-756
Abstract
Bladder cancer remains a clinically challenging malignancy, with increasing evidence suggesting that chronic bladder inflammation, such as interstitial cystitis (IC), may contribute to its development. However, the molecular mechanisms linking inflammation to tumorigenesis are poorly understood. Here, we identify coiled-coil domain-containing 8 (CCDC8) as a potential oncogenic factor in bladder cancer. Transcriptomic analysis revealed that CCDC8 is dysregulated in both IC and bladder cancer, with overexpression confirmed in tumor tissues and cell lines. Elevated CCDC8 expression was significantly associated with advanced tumor stage, lymph node metastasis, and poor prognosis, particularly in patients harboring wild-type TP53. Functional studies demonstrated that CCDC8 promotes tumor cell proliferation, migration, and survival in vitro, and enhances tumor growth in vivo. Mechanistically, CCDC8 interacts with the E3 ubiquitin ligase scaffold protein CUL7, facilitating proteasome-dependent degradation of P53, thereby suppressing its downstream effectors such as P21 and BAX. Pharmacological inhibition of neddylation with MLN4924 restored P53 levels and reversed the oncogenic effects of CCDC8 both in vitro and in vivo. Together, these findings highlight a novel mechanism of P53 regulation in bladder cancer, position CCDC8 as a potential biomarker and therapeutic target, and suggest a molecular link between chronic bladder inflammation and malignant transformation.Keywords
Funding Information
- Natural Science Foundation of Fujian Province (2025J08052)
- Fujian Provincial Department of Science and Technology (2024Y9080)
This publication has 57 references indexed in Scilit:
- Current State of Bladder Preservation in High Grade Non-Muscle Invasive Bladder Cancer and Localized Muscle Invasive Bladder CancerCurrent Oncology Reports, 2025
- MIS18BP1 promotes bladder cancer cell proliferation and growth via inactivating P53 signaling pathwayMedical Oncology, 2025
- RNA-Seq and Gene Set Enrichment Analysis (GSEA) in Peripheral Blood Mononuclear Cells (PBMCs)2025
- Clinical and molecular spectrum along with genotype–phenotype correlation of 25 patients diagnosed with 3 M syndrome: a study from TurkeyEuropean Journal of Pediatrics, 2024
- Current and Potential Roles of Ferroptosis in Bladder CancerCurrent Medical Science, 2023
- Regulatory network and targeted interventions for CCDC family in tumor pathogenesisCancer Letters, 2023
- Multifocal Xanthogranulomatous cystitis mimicking bladder malignancy: A case report and literature reviewAsian Journal of Surgery, 2022
- Coiled-Coil Domain-Containing (CCDC) Proteins: Functional Roles in General and Male Reproductive PhysiologyReproductive Sciences, 2021
- Cullin7 enhances resistance to trastuzumab therapy in Her2 positive breast cancer via degrading IRS-1 and downregulating IGFBP-3 to activate the PI3K/AKT pathwayCancer Letters, 2019
- Increased risk of bladder cancer following diagnosis with bladder pain syndrome/interstitial cystitisNeurourology and Urodynamics, 2012